AJP - Heart and Circulatory Physiology, Vol 259, Issue 1 211-H217, Copyright © 1990 by American Physiological Society

ARTICLES

Hypertension and hemodilution during cerebral ischemia reduce brain injury and edema

D. J. Cole, J. C. Drummond, T. N. Osborne and J. Matsumura
Department of Anesthesiology, Loma Linda University 92354.

The extent of cerebral injury and edema was determined in isoflurane-anesthetized rats (n = 32) after 180 min of middle cerebral artery occlusion (MCAO) and 120 min of reperfusion. One of the following was employed during the occlusion period only: 1) control, mean arterial pressure [MAP = 131 +/- 7 (SD) mmHg] and hematocrit (43 +/- 2%) were not manipulated; 2) hemodilution, the hematocrit was reduced to 30% with 5% albumin (MAP = 104 +/- 19 mmHg); 3) hemodilution-normotension, hemodilution was established, and MAP was maintained at 131 +/- 9 mmHg with phenylephrine; 4) hemodilution-hypertension, hemodilution was established, and MAP increased to 161 +/- 2 mmHg with phenylephrine. Brain injury was determined with 2,3,5-triphenyltetrazolium chloride, and cerebral edema was assessed by microgravimetry. Brain injury and cerebral edema were less in both phenylephrine groups, compared with the control and hemodilution groups (P less than 0.05). These results are consistent with the premise that if normotension is maintained, hemodilution reduces ischemic brain injury and edema. They also indicate that the addition of phenylephrine-induced hypertension to hemodilution therapy results in a further reduction of ischemic injury without exacerbating cerebral edema.

This article has been cited by other articles:

				S. Schwarz, D. Georgiadis, A. Aschoff, and S. Schwab Effects of Induced Hypertension on Intracranial Pressure and Flow Velocities of the Middle Cerebral Arteries in Patients With Large Hemispheric Stroke Stroke, April 1, 2002; 33(4): 998 - 1004. [Abstract] [Full Text] [PDF]

				D. J. Cole, L. M. Cross, J. C. Drummond, P. M. Patel, and W. K. Jacobsen Thiopentone and methohexital, but not pentobarbitone, reduce early focal cerebral ischemic injury in rats : [Le thiopental et le methohexital, mais non le pentobarbital, reduisent la lesion ischemique cerebrale focale precoce chez les rats] Can J Anesth, September 1, 2001; 48(8): 807 - 814. [Abstract] [Full Text] [PDF]

				L. Belayev, W. Zhao, P. M. Pattany, R. G. Weaver, P. W. Huh, B. Lin, R. Busto, M. D. Ginsberg, S. Mori, and R. J. Traystman Diffusion-Weighted Magnetic Resonance Imaging Confirms Marked Neuroprotective Efficacy of Albumin Therapy in Focal Cerebral Ischemia • Editorial Comment Stroke, December 1, 1998; 29(12): 2587 - 2599. [Abstract] [Full Text] [PDF]

				H. P. Grocott, R. D. Bart, H. Sheng, Y. Miura, R. Steffen, R. D. Pearlstein, D. S. Warner, and E. P. Wei Effects of a Synthetic Allosteric Modifier of Hemoglobin Oxygen Affinity on Outcome From Global Cerebral Ischemia in the Rat • Editorial Comment Stroke, August 1, 1998; 29(8): 1650 - 1655. [Abstract] [Full Text] [PDF]

				G. Rordorf, S. C. Cramer, J. T. Efird, L. H. Schwamm, F. Buonanno, and W. J. Koroshetz Pharmacological Elevation of Blood Pressure in Acute Stroke : Clinical Effects and Safety Stroke, November 1, 1997; 28(11): 2133 - 2138. [Abstract] [Full Text]

				A. Rebel, J. A. Ulatowski, K. Joung, E. Bucci, R. J. Traystman, and R. C. Koehler Regional cerebral blood flow in cats with cross-linked hemoglobin transfusion during focal cerebral ischemia Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H832 - H841. [Abstract] [Full Text] [PDF]